Supplemental Material, Table_S1_(1) - Circulating Biomarker Levels in Patients With Stage 5 Chronic Kidney Disease With Respect to Neurovascular Diseases

Table1_Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease.DOCX

Weiwei Lin (2442850)
Fatemeh Mousavi (1422505)
Benjamin C. Blum (9948518)
Christian F. Heckendorf (1337652)
Jarrod Moore (17454144)
Noah Lampl (17454147)
Mark McComb (17186908)
Sergei Kotelnikov (14839173)
Wenqing Yin (8103020)
Nabil Rabhi (15580352)
Matthew D. Layne (12410985)
Dima Kozakov (152588)
Vipul C. Chitalia (17454150)
Andrew Emili (65325)

February 2024

Background: We hypothesize that the poor survival outcomes of end-stage kidney disease (ESKD) patien...

Supplementary Material for: Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease

Jotwani V.K. (6536273)
Lee A.K. (6536276)
Estrella M.M. (6536279)
Katz R. (6536282)
Garimella P.S. (5371688)
Malhotra R. (4581205)
Rifkin D.E. (6536285)
Ambrosius W. (6536288)
Freedman B.I. (2954181)
Cheung A.K. (4157941)
Raphael K.L. (6536291)
Drawz P. (4161949)
Neyra J.A. (6536294)
Oparil S. (6536297)
Punzi H. (6536300)
Shlipak M.G. (3356243)
Ix J.H. (3388841)
for the SPRINT Research Group (6536303)

April 2019

Background: Kidney tubulointerstitial fibrosis on biopsy is a strong predictor of chronic kidney dis...

Supplementary Material for: CXCL12 in Patients with Chronic Kidney Disease and Healthy Controls: Relationships to Ambulatory 24-Hour Blood Pressure and Echocardiographic Measures

Klimczak-Tomaniak D. (5531402)
Pilecki T. (5531393)
Żochowska D. (5531390)
Sieńko D. (5531384)
Janiszewski M. (5531396)
Pączek L. (5531387)
Kuch M. (5531399)

July 2018

Background/Aims: Chronic kidney disease is a pro-inflammatory condition where the inte...

Supplemental Material, Table_S1 - Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney Disease

Justin Lee (277033)
Jack Bontekoe (5893469)
Brandon Trac (5893472)
Vinod Bansal (3619343)
José Biller (5893475)
Debra Hoppensteadt (232860)
Paula Maia (5799710)
Amanda Walborn (5893478)
Jawed Fareed (232865)

October 2018

Supplemental Material, Table_S1 for Biomarker Profiling of Neurovascular Diseases in Patients with S...

Supplementary_table_1 – Supplemental material for Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study

Hind H. Lazrak (5591951)
Emilie René (5591954)
Naoual Elftouh (4095028)
Jean-Philippe Lafrance (4095019)

August 2018

Supplemental material, Supplementary_table_1 for Association Between Low-Molecular-Weight Heparin...

Additional file 1: Table S1. of Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study

Holly Hutton (3848926)
Adeera Levin (3415730)
Jagbir Gill (3848923)
Ognjenka Djurdjev (3848917)
Mila Tang (3848914)
Sean Barbour (3848920)

March 2017

The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...

Supplementary Material for: Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters

Roetker N.S. (6382205)
Peng Y. (3215130)
Ashfaq A. (6382208)
Gilbertson D.T. (4154074)
Wetmore J.B. (3098679)

February 2019

Background: Mineral and bone disorder (MBD) is common in patients with chronic kidney disease (CKD),...

sj-pdf-1-jcb-10.1177_0271678X231151621 - Supplemental material for Dialysis adequacy and hemoglobin levels predict cerebral atrophy in maintenance-hemodialysis patients

Ming-Xuan Cao (14451692)
Jia Xiao (553000)
Hua-Min Qin (14451695)
Zhi-Hong Wang (529684)
Johannes Boltze (295414)
Shu-Xin Liu (13233120)
Shen Li (432920)

January 2023

Supplemental material, sj-pdf-1-jcb-10.1177_0271678X231151621 for Dialysis adequacy and hemoglobin l...

Supplemental_Tables_for_PAI-1_RTR – Supplemental material for Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: Analytical and biological considerations

Richard G Jung (6683888)
Trevor Simard (357045)
Pietro Di Santo (5337563)
Alisha Labinaz (5337560)
Robert Moreland (6683891)
Anne-Claire Duchez (683627)
Kamran Majeed (6579464)
Pouya Motazedian (5337569)
Rebecca Rochman (6579470)
Young Jung (3426749)
Benjamin Hibbert (88827)

May 2019

Supplemental material, Supplemental_Tables_for_PAI-1_RTR for Performance of plasminogen activator in...

Additional file 1: Table S1. of Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)

Jun Yuan (356273)
Xin-Rong Zou (3640294)
Si-Ping Han (3640291)
Hong Cheng (112057)
Lan Wang (85307)
Jin-Wei Wang (3640288)
Lu-Xia Zhang (2141392)
Ming-Hui Zhao (160760)
Xiao-Qin Wang (1600645)

January 2017

Anticipated and actual target distributions of CKD etiology and renal function, C-STRIDE study (Nov ...

Supplementary Figure and tables -Supplemental material for Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare

D J Go (5500055)
J Y Lee (5500049)
M J Kang (5500067)
E Y Lee (5500052)
E B Lee (5500058)
E C Yi (5500064)
Y W Song (5500061)

June 2018

Supplemental material, Supplementary Figure and tables for Urinary vitamin D-binding protein, a n...

SupplementalFile5 – Supplemental material for Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

Peter Utnes (6447464)
Cecilie Løkke (31211)
Trond Flægstad (31215)
Christer Einvik (31216)

March 2019

Supplemental material, SupplementalFile5 for Clinically Relevant Biomarker Discovery in High-Risk Re...

Table_1_Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit.docx

Qiang Miao (497115)
Bei Cai (160529)
Qian Niu (425660)
Junlong Zhang (295628)

December 2022

AimsTo investigate the changes in lung cancer-related serum tumor markers in patients with chronic k...

Forest plots of the associations between serum levels of renal biomarkers and the risk of cardiovascular events among patients with chronic renal failure: (A) free PCS, (B) free IS, (C) albumin, (D) creatinine, (E) PTH.

Cheng-Jui Lin (769644)
Vincent Wu (769645)
Pei-Chen Wu (141736)
Chih-Jen Wu (769646)

July 2015

Forest plots of the associations between serum levels of renal biomarkers and the risk of cardiov...

Niki_Final_Uremia_PAD_Review_12-12-18_final_supp_table_1 – Supplemental material for Unique aspects of peripheral artery disease in patients with chronic kidney disease

Nkiruka V Arinze (6419183)
Andrew Gregory (2003713)
Jean M Francis (6419186)
Alik Farber (6419189)
Vipul C Chitalia (6419192)

March 2019

Supplemental material, Niki_Final_Uremia_PAD_Review_12-12-18_final_supp_table_1 for Unique aspects o...

Table1_Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease.DOCX

Weiwei Lin (2442850)
Fatemeh Mousavi (1422505)
Benjamin C. Blum (9948518)
Christian F. Heckendorf (1337652)
Jarrod Moore (17454144)
Noah Lampl (17454147)
Mark McComb (17186908)
Sergei Kotelnikov (14839173)
Wenqing Yin (8103020)
Nabil Rabhi (15580352)
Matthew D. Layne (12410985)
Dima Kozakov (152588)
Vipul C. Chitalia (17454150)
Andrew Emili (65325)

February 2024

Background: We hypothesize that the poor survival outcomes of end-stage kidney disease (ESKD) patien...

Supplementary Material for: Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease

Jotwani V.K. (6536273)
Lee A.K. (6536276)
Estrella M.M. (6536279)
Katz R. (6536282)
Garimella P.S. (5371688)
Malhotra R. (4581205)
Rifkin D.E. (6536285)
Ambrosius W. (6536288)
Freedman B.I. (2954181)
Cheung A.K. (4157941)
Raphael K.L. (6536291)
Drawz P. (4161949)
Neyra J.A. (6536294)
Oparil S. (6536297)
Punzi H. (6536300)
Shlipak M.G. (3356243)
Ix J.H. (3388841)
for the SPRINT Research Group (6536303)

April 2019

Background: Kidney tubulointerstitial fibrosis on biopsy is a strong predictor of chronic kidney dis...

Supplementary Material for: CXCL12 in Patients with Chronic Kidney Disease and Healthy Controls: Relationships to Ambulatory 24-Hour Blood Pressure and Echocardiographic Measures

Klimczak-Tomaniak D. (5531402)
Pilecki T. (5531393)
Żochowska D. (5531390)
Sieńko D. (5531384)
Janiszewski M. (5531396)
Pączek L. (5531387)
Kuch M. (5531399)

July 2018

Background/Aims: Chronic kidney disease is a pro-inflammatory condition where the inte...

Supplemental Material, Table_S1 - Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney Disease

Justin Lee (277033)
Jack Bontekoe (5893469)
Brandon Trac (5893472)
Vinod Bansal (3619343)
José Biller (5893475)
Debra Hoppensteadt (232860)
Paula Maia (5799710)
Amanda Walborn (5893478)
Jawed Fareed (232865)

October 2018

Supplemental Material, Table_S1 for Biomarker Profiling of Neurovascular Diseases in Patients with S...

Supplementary_table_1 – Supplemental material for Association Between Low-Molecular-Weight Heparin and Risk of Bleeding Among Hemodialysis Patients: A Retrospective Cohort Study

Hind H. Lazrak (5591951)
Emilie René (5591954)
Naoual Elftouh (4095028)
Jean-Philippe Lafrance (4095019)

August 2018

Supplemental material, Supplementary_table_1 for Association Between Low-Molecular-Weight Heparin...

Additional file 1: Table S1. of Cardiovascular risk is similar in patients with glomerulonephritis compared to other types of chronic kidney disease: a matched cohort study

Holly Hutton (3848926)
Adeera Levin (3415730)
Jagbir Gill (3848923)
Ognjenka Djurdjev (3848917)
Mila Tang (3848914)
Sean Barbour (3848920)

March 2017

The biomarker hazard ratios using Cox proportional hazards models that included GN vs non-GN CKD and...

Supplementary Material for: Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters

Roetker N.S. (6382205)
Peng Y. (3215130)
Ashfaq A. (6382208)
Gilbertson D.T. (4154074)
Wetmore J.B. (3098679)

February 2019

Background: Mineral and bone disorder (MBD) is common in patients with chronic kidney disease (CKD),...

sj-pdf-1-jcb-10.1177_0271678X231151621 - Supplemental material for Dialysis adequacy and hemoglobin levels predict cerebral atrophy in maintenance-hemodialysis patients

Ming-Xuan Cao (14451692)
Jia Xiao (553000)
Hua-Min Qin (14451695)
Zhi-Hong Wang (529684)
Johannes Boltze (295414)
Shu-Xin Liu (13233120)
Shen Li (432920)

January 2023

Supplemental material, sj-pdf-1-jcb-10.1177_0271678X231151621 for Dialysis adequacy and hemoglobin l...

Supplemental_Tables_for_PAI-1_RTR – Supplemental material for Performance of plasminogen activator inhibitor-1 as a biomarker in patients undergoing coronary angiography: Analytical and biological considerations

Richard G Jung (6683888)
Trevor Simard (357045)
Pietro Di Santo (5337563)
Alisha Labinaz (5337560)
Robert Moreland (6683891)
Anne-Claire Duchez (683627)
Kamran Majeed (6579464)
Pouya Motazedian (5337569)
Rebecca Rochman (6579470)
Young Jung (3426749)
Benjamin Hibbert (88827)

May 2019

Supplemental material, Supplemental_Tables_for_PAI-1_RTR for Performance of plasminogen activator in...

Additional file 1: Table S1. of Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: results from the Chinese cohort study of chronic kidney disease (C-STRIDE)

Jun Yuan (356273)
Xin-Rong Zou (3640294)
Si-Ping Han (3640291)
Hong Cheng (112057)
Lan Wang (85307)
Jin-Wei Wang (3640288)
Lu-Xia Zhang (2141392)
Ming-Hui Zhao (160760)
Xiao-Qin Wang (1600645)

January 2017

Anticipated and actual target distributions of CKD etiology and renal function, C-STRIDE study (Nov ...

Supplementary Figure and tables -Supplemental material for Urinary vitamin D-binding protein, a novel biomarker for lupus nephritis, predicts the development of proteinuric flare

D J Go (5500055)
J Y Lee (5500049)
M J Kang (5500067)
E Y Lee (5500052)
E B Lee (5500058)
E C Yi (5500064)
Y W Song (5500061)

June 2018

Supplemental material, Supplementary Figure and tables for Urinary vitamin D-binding protein, a n...

SupplementalFile5 – Supplemental material for Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma

Peter Utnes (6447464)
Cecilie Løkke (31211)
Trond Flægstad (31215)
Christer Einvik (31216)

March 2019

Supplemental material, SupplementalFile5 for Clinically Relevant Biomarker Discovery in High-Risk Re...

Table_1_Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit.docx

Qiang Miao (497115)
Bei Cai (160529)
Qian Niu (425660)
Junlong Zhang (295628)

December 2022

AimsTo investigate the changes in lung cancer-related serum tumor markers in patients with chronic k...

Forest plots of the associations between serum levels of renal biomarkers and the risk of cardiovascular events among patients with chronic renal failure: (A) free PCS, (B) free IS, (C) albumin, (D) creatinine, (E) PTH.

Cheng-Jui Lin (769644)
Vincent Wu (769645)
Pei-Chen Wu (141736)
Chih-Jen Wu (769646)

July 2015

Forest plots of the associations between serum levels of renal biomarkers and the risk of cardiov...

Niki_Final_Uremia_PAD_Review_12-12-18_final_supp_table_1 – Supplemental material for Unique aspects of peripheral artery disease in patients with chronic kidney disease

Nkiruka V Arinze (6419183)
Andrew Gregory (2003713)
Jean M Francis (6419186)
Alik Farber (6419189)
Vipul C Chitalia (6419192)

March 2019

Supplemental material, Niki_Final_Uremia_PAD_Review_12-12-18_final_supp_table_1 for Unique aspects o...

Table1_Integrated metabolomics and proteomics reveal biomarkers associated with hemodialysis in end-stage kidney disease.DOCX

Weiwei Lin (2442850)
Fatemeh Mousavi (1422505)
Benjamin C. Blum (9948518)
Christian F. Heckendorf (1337652)
Jarrod Moore (17454144)
Noah Lampl (17454147)
Mark McComb (17186908)
Sergei Kotelnikov (14839173)
Wenqing Yin (8103020)
Nabil Rabhi (15580352)
Matthew D. Layne (12410985)
Dima Kozakov (152588)
Vipul C. Chitalia (17454150)
Andrew Emili (65325)

February 2024

Background: We hypothesize that the poor survival outcomes of end-stage kidney disease (ESKD) patien...

Supplementary Material for: Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease

Jotwani V.K. (6536273)
Lee A.K. (6536276)
Estrella M.M. (6536279)
Katz R. (6536282)
Garimella P.S. (5371688)
Malhotra R. (4581205)
Rifkin D.E. (6536285)
Ambrosius W. (6536288)
Freedman B.I. (2954181)
Cheung A.K. (4157941)
Raphael K.L. (6536291)
Drawz P. (4161949)
Neyra J.A. (6536294)
Oparil S. (6536297)
Punzi H. (6536300)
Shlipak M.G. (3356243)
Ix J.H. (3388841)
for the SPRINT Research Group (6536303)

April 2019

Background: Kidney tubulointerstitial fibrosis on biopsy is a strong predictor of chronic kidney dis...

Supplementary Material for: CXCL12 in Patients with Chronic Kidney Disease and Healthy Controls: Relationships to Ambulatory 24-Hour Blood Pressure and Echocardiographic Measures

Klimczak-Tomaniak D. (5531402)
Pilecki T. (5531393)
Żochowska D. (5531390)
Sieńko D. (5531384)
Janiszewski M. (5531396)
Pączek L. (5531387)
Kuch M. (5531399)

July 2018

Background/Aims: Chronic kidney disease is a pro-inflammatory condition where the inte...

Supplemental Material, Table_S1_(1) - Circulating Biomarker Levels in Patients With Stage 5 Chronic Kidney Disease With Respect to Neurovascular Diseases

Abstract

Extracted data

Supplemental Material, Table_S1_(1) - Circulating Biomarker Levels in Patients With Stage 5 Chronic Kidney Disease With Respect to Neurovascular Diseases

Abstract

Extracted data

Related items

Related items